These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2683008)

  • 41. Further experience with long-term captopril therapy in severe refractory congestive heart failure.
    King J; Steingo L; Barlow JB; Jardine R; Goldman AP; Allman B; Pocock WA
    S Afr Med J; 1983 Sep; 64(14):510-5. PubMed ID: 6353616
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The influence of meproscillarin on human left ventricular function (author's transl)].
    Turina J; Krayenbühl HP
    Arzneimittelforschung; 1978; 28(3a):555-7. PubMed ID: 580589
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Captopril in the treatment of chronic CHF.
    Kennedy GT
    Crit Care Nurse; 1990 Feb; 10(2):39-46. PubMed ID: 2192828
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiovascular effects of dibutyryl cyclic AMP in patients with congestive heart failure--comparison with dobutamine and captopril.
    Nakanishi M; Yokota Y; Fukuzaki H
    Jpn Circ J; 1988 Jun; 52(6):503-10. PubMed ID: 2845163
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term hemodynamic and clinical efficacy of captopril therapy in ambulatory management of severe chronic congestive heart failure.
    Awan NA; Amsterdam EA; Hermanovich J; Bommer WJ; Needham KE; Mason DT
    Am Heart J; 1982 Apr; 103(4 Pt 1):474-9. PubMed ID: 6801943
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effect of captopril on the life expectancy of patients with chronic heart failure].
    Kleber FX
    Herz; 1987 Dec; 12 Suppl 1():38-45. PubMed ID: 3325395
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Morphofunctional state of the heart and activity of the kallikrein-kinin system in patients with chronic heart failure during treatment with captopril].
    Ol'binskaia LI; Golokolenova GM; Bol'shakova TD; Kuznetsov VA
    Klin Med (Mosk); 1991 Oct; 69(10):48-50. PubMed ID: 1837324
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of severity of heart failure on the efficacy of angiotensin-converting enzyme inhibition.
    Kleber FX; Niemöller L; Fischer M; Doering W
    Am J Cardiol; 1991 Nov; 68(14):121D-126D. PubMed ID: 1746416
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Long-term treatment of congestive heart failure with captopril].
    Wang H
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Apr; 18(2):74-6. PubMed ID: 2209405
    [No Abstract]   [Full Text] [Related]  

  • 50. [Echocardiographic evaluation of left ventricular function during therapy with cardiovascularly effective drugs].
    Stefan G
    Z Kardiol; 1976 Aug; 65(8):669-79. PubMed ID: 969820
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Determinants of clinical response and survival in patients with congestive heart failure treated with captopril.
    Creager MA; Faxon DP; Halperin JL; Melidossian CD; McCabe CH; Schick EC; Ryan TJ
    Am Heart J; 1982 Nov; 104(5 Pt 2):1147-54. PubMed ID: 6291360
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group.
    J Am Coll Cardiol; 1983 Oct; 2(4):755-63. PubMed ID: 6350401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of captopril and digoxin in the treatment of patients with mild-to-moderate chronic congestive heart failure.
    Heck I; Lüderitz B; Müller HM; Esser H
    Clin Ther; 1995; 17(2):270-9. PubMed ID: 7614527
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Which vasodilator drug in patients with chronic heart failure? A randomised comparison of captopril and hydralazine.
    Schofield PM; Brooks NH; Lawrence GP; Testa HJ; Ward C
    Br J Clin Pharmacol; 1991 Jan; 31(1):25-32. PubMed ID: 2015167
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiovascular effects of a newly synthesized cardiotonic agent (TA-064) on normal and diseased hearts.
    Kino M; Hirota Y; Yamamoto S; Sawada K; Moriguchi M; Kotaka M; Kubo S; Kawamura K
    Am J Cardiol; 1983 Mar; 51(5):802-10. PubMed ID: 6829441
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A case of successful use of captopril in severe congestive heart failure].
    Belokrinitskaia OA; Engel'gardt TI; Rumiantseva IuN
    Sov Med; 1991; (6):87-8. PubMed ID: 1887318
    [No Abstract]   [Full Text] [Related]  

  • 57. Congestive heart failure in elderly patients: controlled study of delapril versus captopril.
    Acanfora D; Lanzillo T; Papa A; Longobardi G; Furgi G; Rengo C; Melillo E; Rengo F
    Am J Cardiol; 1995 Jun; 75(18):37F-43F. PubMed ID: 7778533
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Complementary combined captopril and terbutaline therapy in severe chronic congestive heart failure.
    Awan NA; Needham KE; Lui H; Rutledge J; Amsterdam EA; Mason DT
    Am Heart J; 1982 Nov; 104(5 Pt 2):1224-8. PubMed ID: 6753553
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acute and chronic arterial and venous effects of captopril in congestive cardiac failure.
    Capewell S; Taverner D; Hannan WJ; Muir AL
    BMJ; 1989 Oct; 299(6705):942-5. PubMed ID: 2508945
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Large artery function in patients with chronic heart failure. Studies of brachial artery diameter and hemodynamics.
    Arnold JM; Marchiori GE; Imrie JR; Burton GL; Pflugfelder PW; Kostuk WJ
    Circulation; 1991 Dec; 84(6):2418-25. PubMed ID: 1959197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.